Pathstone Family Office’s Qiagen QGEN Stock Holding History

Pathstone Family Office’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,886	Closed	-$106K	–	1183
2020 Q4	$106K	Buy	+1,886	New	+$101K	﹤0.01%	377

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pathstone Family Office's QGEN Position: Q1 2021 in Review

Pathstone Family Office sold out of Qiagen (QGEN) in Q1 2021, closing a stake of 1,886 shares — an estimated $106K sold.

Pathstone Family Office first reported a position in QGEN in Q4 2020 and held it in 1 quarter. The position peaked at $106K in Q4 2020. 274 funds tracked by Wall St. Rank hold QGEN as of Q1 2021.

Pathstone Family Office reported no remaining Qiagen position as of Q1 2021 after selling out during the quarter.
Pathstone Family Office sold 1,886 Qiagen shares in Q1 2021, an estimated $106K.
Pathstone Family Office first reported a position in Qiagen in Q4 2020 and held it in 1 quarter.
Pathstone Family Office's Qiagen position peaked at $106K in Q4 2020.
274 funds tracked by Wall St. Rank held Qiagen as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.